Kura Oncology Inc Live Stock Price Today, Share Analysis and Chart

Name: Kura Oncology Inc: Is Infosys Ltd. worth buying?
Item: Kura Oncology Inc
Rating: 0.99940275
Author: Trendlyne DVM scores

Momentum Trap

about

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathway...

8.83 0.08 (0.91%)

29.30% Fall from 52W High

773.1K

XNAS Volume

XNAS 30 Apr, 2026 4:03 PM (EDT)

Board Meeting

The next board meeting for Kura Oncology Inc is on 01 May 2026 for the purpose of Kura Oncology Inc First Quarter Earnings Results for 2026 See details

Low Financial Strength

11.1 / 100

Expensive Valuation

12.0 / 100

Technically Neutral

45.7 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 253%

12 analysts

Kura Oncology Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Kura Oncology Inc Live Stock Price Today, Share Analysis and Chart

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathway...

29.30% Fall from 52W High

SWOT Analysis

Kura Oncology Inc Live Price Chart